The brain's cerebellum may ease alcohol withdrawal symptoms

A shaky hand, a racing heart, a wave of dread; alcohol withdrawal can feel like your body has turned against you. For many ...
The Tufts Daily

Dissertation Diaries: Nicholas Mandel

Welcome back to a new semester of Dissertation Diaries. As a reminder, this is the series where we highlight Ph.D. students ...

What is consciousness? Science faces its hardest problem yet

Koch, who studied vision, thought that by measuring people's brain responses as they looked at special optical illusions, ...

LimX COSA : First Physical-world-native Agentic OS for Humanoid Robots

LimX COSA powers the Oli humanoid with a three-layer stack that blends cognition and whole-body control, enabling agents to ...
Frontiers

Neuronal and Glial Studies in Human Brain Tissue: Research Perspectives and Ethical Considerations

For a long time, the study of the brain has largely focused on neuronal cells. However, neurons develop and interact closely together in space and time with ...

Solid Biosciences Doses First Participant in First-in-Class Phase 1b FALCON Trial Evaluating SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia

About the FALCON Trial FALCON is a first-in-human, open-label, multi-center Phase 1b clinical trial designed to evaluate the safety and tolerability of SGT-212 in participants aged 18-40 who have been ...
Medindia

Rethinking Autism: Why Diversity Matters in Autism Data

Biological heterogeneity in autism can illuminate precision psychiatry and improve insights from primate brain mapping data.
The Manila Times

Solid Biosciences Receives FDA Orphan Drug Designation for SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia

Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company” or "Solid”), a life sciences company developing precision genetic ...
El Adelantado de Segovia

Goodbye to the belief that illness strikes suddenly—Dr. Ángel Durántez warns that the “pre-illness” stage of the body begins at age 35

When it comes to predicting how the human body changes, hardly anyone in the medical world has a better perspective than ...

Solid Biosciences Inc.: Solid Biosciences Doses First Participant in First-in-Class Phase 1b FALCON Trial Evaluating SGT-212 Dual-Route Gene Therapy for the Treatment of ...

Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company" or "Solid"), a life sciences company developing precision genetic medicines for neuromuscular ...
Discover Magazine

Giant Rats Grew 14 Times Larger Than Their Mainland Relatives 650,000 Years Ago, but Their Brains Did Not

Learn how CT scans of fossil skulls were used to trace changes in brain regions and sensory priorities in ancient giant rats.

Solid Biosciences Inc.: Solid Biosciences Receives FDA Orphan Drug Designation for SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich's Ataxia

SGT-212 has received FDA Fast Track, Rare Pediatric Disease and Orphan Drug designations - - Dosing of the first participant in the Phase 1b FALCON trial has been completed, with initial data expected ...